Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,063Revenue (TTM) $M849Net Margin (%)1.6Altman Z-Score0.9
Enterprise Value $M3,817EPS (TTM) $0.1Operating Margin %2.8Piotroski F-Score5
P/E(ttm)212Beneish M-Score-1.4Pre-tax Margin (%)-19.1Higher ROA y-yY
Price/Book2.410-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales3.65-y EBITDA Growth Rate %--Current Ratio2.0Lower Leverage y-yY
Price/Free Cash Flow10.0y-y EBITDA Growth Rate %199ROA % (ttm)0.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)1.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M160ROIC % (ttm)-5.9Gross Margin Increase y-yN

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HZNPJoel Greenblatt 2016-03-31 Reduce-0.24%$14.02 - $21.67
($17.57)
$ 18.998%Reduce -49.21%1,053,933
HZNPJulian Robertson 2016-03-31 Add0.19%$14.02 - $21.67
($17.57)
$ 18.998%Add 5.45%868,477
HZNPSteve Mandel 2016-03-31 Reduce-0.15%$14.02 - $21.67
($17.57)
$ 18.998%Reduce -10.28%13,997,232
HZNPKen Heebner 2016-03-31 Add0.09%$14.02 - $21.67
($17.57)
$ 18.998%Add 60.98%330,000
HZNPJulian Robertson 2015-12-31 Buy 2.3%$13.12 - $22.58
($19.53)
$ 18.99-3%New holding823,577
HZNPJoel Greenblatt 2015-12-31 Buy 0.49%$13.12 - $22.58
($19.53)
$ 18.99-3%New holding2,075,017
HZNPKen Heebner 2015-12-31 Buy 0.15%$13.12 - $22.58
($19.53)
$ 18.99-3%New holding205,000
HZNPRon Baron 2015-12-31 Sold Out $13.12 - $22.58
($19.53)
$ 18.99-3%Sold Out0
HZNPSteve Mandel 2015-09-30 Add1.03%$16.81 - $38.45
($31.59)
$ 18.99-40%Add 386.77%15,600,988
HZNPRon Baron 2015-09-30 Buy $16.81 - $38.45
($31.59)
$ 18.99-40%New holding31,999
HZNPSteve Mandel 2015-06-30 Buy 0.42%$25.6 - $34.74
($30.45)
$ 18.99-38%New holding3,204,972
HZNPJoel Greenblatt 2015-03-31 Sold Out -0.011%$12.8 - $25.97
($18.33)
$ 18.994%Sold Out0
HZNPJoel Greenblatt 2014-12-31 Add$10.61 - $13.47
($12.51)
$ 18.9952%Add 33.48%107,898
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
($11.52)
$ 18.9965%Add 39.93%80,834
HZNPJoel Greenblatt 2014-06-30 Buy 0.01%$12.02 - $16.32
($14.25)
$ 18.9933%New holding57,769
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Nohria VirinderDirector 2016-06-15Sell25,000$17.697.35view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2016-02-26Sell4,100$20-5.05view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-12-10Sell4,456$20-5.05view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-09-21Sell7,750$31.78-40.25view
Watkins ThomasDirector 2015-08-19Buy10,000$31.32-39.37view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-07-15Sell26,887$35.55-46.58view
Himawan JeffDirector 2015-03-13Sell554,564$22.44-15.37view
Himawan JeffDirector 2015-03-10Sell1,614,827$21.85-13.09view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.0557.59view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2014-11-19Sell24,999$12.0557.59view

Press Releases about HZNP :

Quarterly/Annual Reports about HZNP:

News about HZNP:

Articles On GuruFocus.com
Julian Robertson Buys 8 New Stakes in 4th Quarter Mar 09 2016 
Sheets Smith Wealth Management Buys Companies With no Debts Sep 01 2015 
Horizon Pharma Leads Stock Returns in Health Care Industry Aug 24 2015 
Mandel’s Lone Pine Takes Stake in Growing Horizon Pharma Jul 28 2015 
M&A’s Driving The Stock Indexes Ahead Apr 06 2015 
Biotech Effectiveness: Horizon Pharma, Zafgen, XOMA Corp Mar 09 2015 

More From Other Websites
Nuvo Pharmaceuticals™ Inc. Announces Pennsaid 2% Phase 3 Trial to Support Regulatory Approvals in... Jul 13 2016
Check out Horizon’s Huge Upside Potential Jul 12 2016
Horizon Pharma (HZNP) Stock Rises, Morgan Stanley Upgrades Jul 11 2016
Morning Movers: Alexion Pharma Gains on Upgrade; Alcoa Rises Ahead of Earnings Jul 11 2016
Horizon Pharma upgraded by Morgan Stanley Jul 11 2016
Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016 Jul 07 2016
Inside Horizon’s Orphan and Rheumatology Business Unit Jul 07 2016
What’s Really Driving Horizon’s Valuation? Jul 07 2016
Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016 Jul 07 2016
The Truth behind Horizon’s EV-to-EBITDA Performance Jun 30 2016
How Is Horizon Pharma Looking on a Price-to-Sales Basis? Jun 30 2016
Horizon (HZNP) Stock Up on Ravicti Label Expansion Filing Jun 30 2016
Horizon Pharma (HZNP) Stock Closed Up as BMO Initiates Coverage Jun 29 2016
Clinigen Group - New MA program with Horizon Pharma Jun 29 2016
Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTI(R) (glycerol... Jun 29 2016
Clinigen and Horizon Pharma enter partnership to initiate European Managed Access program for... Jun 29 2016
Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTI(R) (glycerol... Jun 29 2016
Here’s Why Traders Are Watching These Stocks Today Jun 28 2016
Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : June 28, 2016 Jun 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)